Clinical trial
MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
NCT00301652 · Nanjing University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00301652 |
|---|---|
| Title | MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis |
| Official title | Mycophenolate Mofetil Versus Cyclophosphamide in the Induction Treatment of ANCA Associated Vasculitis |
| Lead sponsor | Nanjing University School of Medicine, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Vasculitis, Anti-Neutrophil Cytoplasmic Antibody |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil |
| Enrollment | 60 |
| Start date | Jun 1, 2003 |
| Primary completion | Apr 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Mar 13, 2006 |
| Last update posted | Jun 8, 2010 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: